These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Pancreatic cancer manifesting as liver metastases and eosinophillic leukemoid reaction: a case report and review of literature. Ashdhir P; Jain P; Pokharna R; Nepalia S; Sharma SS Am J Gastroenterol; 2008 Apr; 103(4):1052-4. PubMed ID: 18397441 [No Abstract] [Full Text] [Related]
32. Salvage plasmapheresis for small-for-size syndrome following hepatic resection for colorectal liver metastases. Sotiropoulos GC; Lang H; Herget-Rosenthal S; Molmenti EP; Baba HA; Karaliotas C; Broelsch CE; Saner FH Int J Colorectal Dis; 2008 May; 23(5):553. PubMed ID: 18060418 [No Abstract] [Full Text] [Related]
33. Major hepatic resection reduces the probability of intrahepatic recurrences following resection of colorectal carcinoma liver metastases. Nagakura S; Shirai Y; Yokoyama N; Wakai T; Suda T; Hatakeyama K Hepatogastroenterology; 2003; 50(51):779-83. PubMed ID: 12828084 [TBL] [Abstract][Full Text] [Related]
34. More tools, new strategies: Enlarging the therapeutic scope for the patient with liver metastases from colorectal cancer. Wagman LD J Surg Oncol; 2007 Jan; 95(1):1-3. PubMed ID: 17192882 [No Abstract] [Full Text] [Related]
35. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724 [TBL] [Abstract][Full Text] [Related]
36. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433 [TBL] [Abstract][Full Text] [Related]
37. Importance of intra-individual variation in tumour volume of hepatic colorectal metastases. Takahashi S; Konishi M; Nakagohri T; Gotohda N; Hanaoka T; Saito N; Kinoshita T Eur J Surg Oncol; 2006 Dec; 32(10):1195-200. PubMed ID: 16968660 [TBL] [Abstract][Full Text] [Related]
38. [Glucagonoma: evolution and treatment]. Carvajal C; Azabache V; Lobos P; Ibarra A Rev Med Chil; 2002 Jun; 130(6):671-6. PubMed ID: 12194691 [TBL] [Abstract][Full Text] [Related]
39. [Strategy of treatment of patients with colorectal cancer with hepatic metastases]. Kalmakhelidze LG; Mosidze BA; Megrelishvili GZ Georgian Med News; 2005 Dec; (129):19-22. PubMed ID: 16444021 [TBL] [Abstract][Full Text] [Related]
40. Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas. Katayama M; Funakoshi A; Sumii T; Sanzen N; Sekiguchi K Cancer Lett; 2005 Jul; 225(1):167-76. PubMed ID: 15922869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]